Categories Earnings, Retail

Kirkland’s Q2 results miss expectations

Kirkland’s Inc. (NASDAQ: KIRK) missed market estimates for revenue and earnings in the second quarter of 2019. Analysts had forecast a loss of $0.67 per share on revenue of $126 million. Shares plummeted over 11% in premarket hours on Thursday.  

On a GAAP basis, the company reported a net loss of $17.1 million, or $1.21 per share, versus $6.7 million, or $0.43 per share, last year. Adjusted net loss was $14.9 million, or $1.05 per share.

Net sales fell 10.5% year-over-year to $119.9 million. Comparable store sales, including e-commerce sales, decreased 11.2% compared to a decrease of 3.9% in the prior-year quarter.

Image Courtesy: Kirkland’s

The comp stores sales decline was driven by a drop in store sales, partly offset by a growth in ecommerce sales. Store sales were hurt by negative store traffic and a decline in average ticket, partly offset by an improvement in conversion. Gains in traffic and conversion helped drive a 22% growth in ecommerce sales but were partly offset by a drop in average ticket.

Also see: Signet Q2 2020 Earnings Report

During the quarter, Kirkland’s faced challenges due to shifts in shopping patterns of customers and saw double-digit declines in store traffic which in turn weighed on margins. The company expects near-term financial results to be impacted by higher promotional and marketing activity to drive traffic and bring in new customers.

Kirkland’s opened one store and closed one store during the quarter, bringing the total number of stores to 431 at quarter-end. 

For fiscal 2019, the company expects net loss to range from $1.25 to $1.50 per share. 

Get access to timely and accurate verbatim transcripts that are published within hours of the event.

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top